Inventor · disambiguated record
Eva Figueroa Navarro
Also filed as: NAVARRO EVA F · NAVARRO EVA FIGUEROA
10 granted patents·8 pending applications·145 citations·filing 2004–2014
90Inventor score
Top patents by PatentIndex Score
18 records- 0196US7754725B2Dihydroxyphenyl isoindolymethanonesASTEX THERAPEUTICS LTD·Filed 2007·Granted Jul 13, 2010·22 cites·10 claims
- 0295US8106057B2Dihydroxyphenyl isoindolylmethanonesCHESSARI GIANNI·Filed 2010·Granted Jan 31, 2012·19 cites·7 claims
- 0394US7700625B2Hydroxybenzamide derivatives and their use as inhibitors of Hsp90ASTEX THERAPEUTICS LTD·Filed 2007·Granted Apr 20, 2010·25 cites·10 claims
- 0492US8101648B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90CHESSARI GIANNI·Filed 2006·Granted Jan 24, 2012·20 cites·18 claims
- 0591US8110573B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2005·Granted Feb 7, 2012·9 cites·17 claims
- 0690US7977477B2Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2004·Granted Jul 12, 2011·35 cites·23 claims
- 0789US8530469B2Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90CHESSARI GIANNI·Filed 2011·Granted Sep 10, 2013·11 cites·21 claims
- 0879US8778936B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·20 claims
- 0978US8816087B2Hydroxybenzamide derivatives and their use as inhibitors of Hsp90CHESSARI GIANNI·Filed 2007·Granted Aug 26, 2014·2 cites·15 claims
- 1066US9914719B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90ASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 13, 2018·0 cites·21 claims
- 1155US2014010892A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Application pending·0 cites
- 1254US2010216782A1Hydroxybenzamide derivatives and their use as inhibitors of hsp90CHESSARI GIANNI·Filed 2010·Application pending·0 cites
- 1352US2008194562A1Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk'sASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 1452US2008306069A1Pyrazole Derivatives for the Inhibition of CDK'S and GSK'SASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 1551US2011224203A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2011·Application pending·0 cites
- 1646US2007105900A1Pharmaceutical compoundsATEX THERAPEUTICS LTD·Filed 2004·Application pending·0 cites
- 1745US2009318500A14-(2, 6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the Treatment of CancerASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 1843US2010160324A1Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinasesASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eva Figueroa Navarro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →